RE: CSDI Portfolio5 Feb 2021 19:32
Two more juggles to report.
1, Sold PDG for miserly 2% profit, to add to GSK position, which is now 22% of p/f **
2. sold HHI at an oposite loss of 2%, to add to my miniscule PFC position, which is now 7% of p/f (up from 3%)
** = expecting a reprimand from A_S for adding to a losing position in midst of big selling pressure/down trend.
I wanted to reduce number of holdings from 13, as several too small to have any impact.
Still got one with <5% of p/f which is ASEI. Need to decide whether to add to make worthwhile or sell and add to existing holding.
A terrible performance this week, dropping 1.4% of p/f value, vs the FTSE's gain of 1.3%.
It is not good when your two largest holdings GSK 22% and IMB 18% drop 7% and 3% respectively.
The addition of GGP and PFC may add some spice to the p/f, while GSK and IMB provide the ballast.
Thanks to A_S, I will be looking at some new sectors to consider, when planning to add about 7.5% in funds in the new tax year.